The global mesoporous silica market is projected to achieve a market size of USD 388.7 million by 2030, with an anticipated CAGR of 10.4% from 2023 to 2030, according to a recent report by Grand View Research, Inc. The primary factor driving this growth is the increasing penetration of mesoporous silica products in the pharmaceutical industry. The properties of mesoporous silica, such as its thermal stability, favorable chemical attributes, and biocompatibility, make it an ideal candidate for use in the pharmaceutical sector, particularly in drug delivery systems. These characteristics are expected to significantly boost demand in the industry over the forecast period.

The market value chain consists of several key stages and players, starting with raw material suppliers, followed by manufacturers, research laboratories, distributors, and ultimately, the end-users. The market is still in a phase of evolving research and development, with a limited number of players engaged in the production and supply of mesoporous silica. The industry is currently dominated by established companies that hold a significant share of the market, though the market remains dynamic with ongoing developments.

The biomedical applications of mesoporous silica are expected to generate the highest demand, particularly due to its role in advanced drug delivery systems. This has led companies to increase their focus on research and development activities to cater to the medical sector's growing needs. As a result, continuous advancements in mesoporous silica technology present substantial growth opportunities in the medical industry, which is expected to drive further market expansion.

Curious about the Mesoporous Silica Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Mesoporous Silica Market Report Highlights

1. SBA Series Segment:

o The SBA series segment dominated the market with a 44.0% revenue share in 2022. This segment is forecast to grow at the fastest CAGR of 11.5% during the forecast period, primarily due to the enhanced thermochemical stability of the SBA series, which is highly sought after for pharmaceutical applications. The material’s stability and performance under extreme conditions make it especially suitable for use in drug delivery systems, encouraging growth in this segment.

2. Drug Delivery Segment:

o The drug delivery segment held a substantial 42.9% revenue share in 2022. This high market share is driven by the high surface area, biocompatibility, and the ease of surface modification offered by mesoporous silica. These properties make it an ideal candidate for use as an active drug ingredient in various treatments, including those for cancer. The ability of mesoporous silica to enhance drug loading and enable controlled drug release is a key factor in its growing popularity in medical treatments.

3. Asia Pacific Market Growth:

o The Asia Pacific region is expected to experience the highest CAGR of 11.5% during the forecast period, in terms of revenue. This growth can be attributed to the rapid expansion of the pharmaceutical industry in the region, as well as the increasing investment in wastewater treatment technologies. With rising industrialization and increasing demand for more efficient pharmaceutical and environmental solutions, the Asia Pacific market is poised to be a significant contributor to the global growth of mesoporous silica.

4. Key Manufacturers and Strategic Focus:

o Major players in the mesoporous silica market, including Merck KGaA and Taiyo International, are heavily focused on adopting new technologies and enhancing their research and development (R&D) activities. This focus on innovation is aimed at gaining a competitive advantage and meeting the diverse application needs of various industries, particularly in pharmaceuticals and environmental technologies. Their investments in R&D are expected to help them lead the way in developing new mesoporous silica products and solutions, further driving market growth.

Mesoporous Silica Market Segmentation

Grand View Research has segmented the global mesoporous silica market on the basis of on product, application, and region:

Mesoporous Silica Product Outlook (Volume, Kilogram; Revenue, USD Million, 2018 - 2030)

• M41S Series

• SBA Series

• Others

Mesoporous Silica Application Outlook (Volume, Kilogram; Revenue, USD Million, 2018 - 2030)

• Catalysts

• Drug Delivery

• Environmental Protection

• Others

Mesoporous Silica Regional Outlook (Volume, Kilogram; Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Italy

o Spain

• Asia Pacific

o China

o Japan

o India

o Taiwan

o South Korea

• Central and South America

o Brazil

o Argentina

• Middle East and Africa

o Saudi Arabia

o UAE

List of Key Players in the Mesoporous Silica Market

• Merck KGaA

• American Elements

• Nanocomposix, Inc.

• Taiyo International

• Mitsubishi Chemical Corporation

• MKnano

• W.R.Grace & Co.

• AGC Chemicals Americas, Inc.

• Glantreo Ltd.

• ACS Material LLC

Order a free sample PDF of the Mesoporous Silica Market Intelligence Study, published by Grand View Research.